Does extended prostate needle biopsy improve the concordance of Gleason scores between biopsy and prostatectomy in the Taiwanese population?

Journal of the Chinese Medical Association

Volumn 75, Issue 3, 2012, Pages 97-101

  Yang, Ching Wei ^a   Lin, Tzu Ping ^a,b   Huang, Yi Hsiu ^a,b   Chung, Hsiao Jen ^a,b   Kuo, Junne Yih ^a,b   Huang, William J S ^a,b   Wu, Howard H H ^a,b   Chang, Yen Hwa ^a,b   Lin, Alex T L ^a,b   Chen, Kuang Kuo ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Gleason score; Grade migration; Needle biopsy; Prostatectomy; Prostatic neoplasm

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PREDICTIVE VALUE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TAIWAN;

AGED; BIOPSY, NEEDLE; HUMANS; MALE; NEOPLASM GRADING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84862825886     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2012.02.001     Document Type: Article

References (27)

1. Gleason D.F., Mellinger G.T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974, 111:58-64.
2. D'Amico A.V., Desjardin A., Chung A., Chen M.H., Schultz D., Whittington R., et al. Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy. Cancer 1998, 82:1887-1896.
3. Olumi A.F., Richie J.P., Schultz D.J., D'Amico A.V. Calculated volume of prostate cancer identifies patients with clinical stage T1C disease at high risk of biochemical recurrence after radical prostatectomy: a preliminary study. Urology 2000, 56:273-277.
4. Mills S.E., Fowler J.E. Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens. Cancer 1986, 57:346-349.
5. Paulson D.F. Impact of radical prostatectomy in the management of clinically localized disease. J Urol 1994, 152:1826-1830.
6. Fukagai T., Namiki T., Namiki H., Carlile R.G., Shimada M., Yoshida H. Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens. Pathol Int 2001, 51:364-370.
7. Carlson G.D., Calvanese C.B., Kahane H., Epstein J.I. Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability. Urology 1998, 51:525-529.
8. Lange P.H., Narayan P. Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy. Urology 1983, 21:113-118.
9. Eskew L.A., Bare R.L., McCullough D.L. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997, 157:199-202.
10. Eskew L.A., Woodruff R.D., Bare R.L., McCullough D.L. Prostate cancer diagnosed by the 5 region biopsy method is significant disease. J Urol 1998, 160:794-796.
11. Klotz L. Active surveillance for prostate cancer: trials and tribulations. World J Urol 2008, 26:437-442.
12. Spires S.E., Cibull M.L., Wood D.P., Miller S., Spires S.M., Banks E.R. Gleason histologic grading in prostatic carcinoma. Correlation of 18-gauge core biopsy with prostatectomy. Arch Pathol Lab Med 1994, 118:705-708.
13. San Francisco I.F., DeWolf W.C., Rosen S., Upton M., Olumi A.F. Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J Urol 2003, 169:136-140.
14. Emiliozzi P., Maymone S., Paterno A., Scarpone P., Amini M., Proietti G., et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy. J Urol 2004, 172:2224-2226.
15. Miyake H., Kurahashi T., Takenaka A., Hara I., Fujisawa M. Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores. Urol Int 2007, 79:302-306.
16. Jeong H., Jeong B.C., Kwak C., Lee E., Lee S.E., Kim T.B. A comparison of prostate cancer detection rates by 12 or 6 core biopsy at different prostate-specific antigen densities in Korean men. World J Urol 2008, 26:395-400.
17. Kim J.W., Lee H.Y., Hong S.J., Chung B.H. Can a 12 core prostate biopsy increase the detection rate of prostate cancer versus 6 core? A prospective randomized study in Korea. Yonsei Med J 2004, 45:671-675.
18. Thickman D., Speers W.C., Philpott P.J., Shapiro H. Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer. J Urol 1996, 156:110-113.
19. Cookson M.S., Fleshner N.E., Soloway S.M., Fair W.R. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol 1997, 157:559-562.
20. Danziger M., Shevchuk M., Antonescu C., Matthews G.J., Fracchia J.A. Predictive accuracy of transrectal ultrasound-guided prostate biopsy: correlations to matched prostatectomy specimens. Urology 1997, 49:863-867.
21. Gregori A., Vieweg J., Dahm P., Paulson D.F. Comparison of ultrasound-guided biopsies and prostatectomy specimens: predictive accuracy of Gleason score and tumor site. Urol Int 2001, 66:66-71.
22. Chen S.S., Chiu L.P., Chen K.K. Comparison of transrectal ultrasound-guided biopsy of the prostate and transurethral resection of the prostate for detection of prostate cancer in patients with moderate lower urinary tract symptoms. J Chin Med Assoc 2010, 73:568-572.
23. Uzzo R.G., Wei J.T., Waldbaum R.S., Perlmutter A.P., Byrne J.C., Vaughan E.D. The influence of prostatic size on cancer detection. Urology 1995, 46:821-826.
24. de la Rosette J.J., Wink M.H., Mamoulakis C., Wondergem N., ten Kate F.J., Zwinderman K., et al. The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL. Cancer 2002, 95:2112-2119.
25. Dong F., Jones J.S., Stephenson A.J., Magi-Galluzzi C., Reuther A.M., Klein E.A. Prostate cancer volume at biopsy predicts clinically significant upgrading. J Urol 2008, 179:896-900.
26. Thompson I., Thrasher J.B., Aus G., Burnett A.L., Canby-Hagino E.D., Cookson M.S., et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007, 177:2106-2131.
27. Koksal I.T., Ozcan F., Kadioglu T.C., Esen T., Kilicaslan I., Tunc M. Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens. Eur Urol 2000, 37:670-674.